Hormone Health Network Introduces Interactive Resources on Diabetes

To raise awareness of the global diabetes epidemic, the Hormone Health Network, the Society’s public education arm, released a new digital toolkit on diabetes. The digital toolkit helps consumers understand the risks of prediabetes and the steps that can be taken to reduce the chances of developing Type 2 diabetes. The resource also includes information on the causes and treatment of hypoglycemia.

The digital toolkit’s interactive resources provide patients and consumers with the information they need to feel empowered to take an active role in their health. Check out the toolkit today.

You may also like

  • Liraglutide Increases Insulin Sensitivity Independent of Weight Loss, Study Shows

    Liraglutide, the glucagon-like peptide-1 receptor (GLP-1R) agonist used to treat type 2 diabetes and obesity, can lead to rapid improvement in insulin sensitivity, according to a study recently published in Diabetes. “We know that GLP-1R agonists promote weight loss, but we were surprised to find that the GLP-1R agonist liraglutide also has rapid effects on…

  • COVID-19 Vaccines and Hyperglycemia in Patients with Type 1 Diabetes

    While proven to be safe, the COVID-19 vaccines could cause some people with type 1 diabetes to see their blood sugar to temporarily spike. The key for both patient and provider is to remain vigilant with glucose testing and insulin dosing post-jab to maintain glycemic control.  In the summer of 2021, a 24-year-old woman presented…